Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Equity (2016 - 2025)

Historic Return on Equity for AtriCure (ATRC) over the last 15 years, with Q3 2025 value amounting to 0.06%.

  • AtriCure's Return on Equity rose 200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.1% for FY2024, which is 300.0% down from last year.
  • Per AtriCure's latest filing, its Return on Equity stood at 0.06% for Q3 2025, which was up 200.0% from 0.08% recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Return on Equity peaked at 0.12% during Q2 2022, and registered a low of 0.15% during Q2 2021.
  • For the 5-year period, AtriCure's Return on Equity averaged around 0.05%, with its median value being 0.08% (2024).
  • Over the last 5 years, AtriCure's Return on Equity had its largest YoY gain of 2600bps in 2022, and its largest YoY loss of -2300bps in 2022.
  • AtriCure's Return on Equity (Quarter) stood at 0.1% in 2021, then tumbled by -199bps to 0.1% in 2022, then soared by 36bps to 0.07% in 2023, then crashed by -47bps to 0.1% in 2024, then surged by 37bps to 0.06% in 2025.
  • Its Return on Equity was 0.06% in Q3 2025, compared to 0.08% in Q2 2025 and 0.08% in Q1 2025.